DALLAS–NEWS–Kendall Law Group, a national securities firm, is investigating ATS Medical, Inc. (NASDAQ:ATSI) for shareholders in connection with the proposed sale of the Company to Medtronic Inc.
DALLAS–NEWS–Kendall Law Group, a national securities firm, is investigating ATS Medical, Inc. (NASDAQ:ATSI) for shareholders in connection with the proposed sale of the Company to Medtronic Inc.
MENLO PARK, Calif.–NEWS–Geron Corporation (Nasdaq:GERN) announced today that the Board of Patent Appeals and Interferences of the U.S. Patent Office (“BPAI”) has reversed an earlier decision from the Patent Office reexamination division that had upheld the claims of U.S. Patent Number 7,029,913. The patent, which is assigned to the Wisconsin Alumni Research Foundation (“WARF”)...
NEW YORK–NEWS–Spring Creek Capital Corporation (OTCBB: SCRK), a healthcare solutions company whose business plan is distributing cutting edge solutions for the medical, pharmaceutical and healthcare markets, has engaged Trilogy Capital Partners to lead its financial marketing and investor relations initiatives. Trilogy’s mandate is to provide investor relations services, drive investor visibility and enhance Spring...
BENTONVILLE, Ark.–NEWS–WellQuest Delists from OTCBB and Continues Listing on PinkSheets; Decision Taken to Fortify Long Term Financial Standing and Continue Expansion Plans
LAKE FOREST, Ill.–NEWS–Akorn, Inc. (NASDAQ: AKRX) a niche generic pharmaceutical company, today announced that two members of the Company’s Board of Directors, Jerry N. Ellis and Randy J. Wall, have notified the Company that they do not intend to seek re-election at the annual meeting of shareholders on May 21, 2010. They will continue...
WESTLAKE, Texas–NEWS–MiddleBrook Pharmaceuticals, Inc. (NASDAQ: MBRK) (“MiddleBrook” or the “Company”) has filed a voluntary petition (the “Petition”) for relief under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”). MiddleBrook will continue to manage and operate its business and assets during the...
EXETER, N.H.–NEWS–CPEX Pharmaceuticals Inc., (NASDAQ: CPEX) today announced the appointment of Robert Forrester to its Board of Directors, effective immediately. In conjunction with the appointment, the Board has temporarily expanded the number of seats on the Board to six. As previously announced, Mr. Forrester will stand for election at CPEX’s annual meeting on May...
HAWTHORNE, N.Y.–NEWS–Taro Pharmaceutical Industries Ltd. (“Taro,” the “Company,” Pink Sheets: TAROF) today provided preliminary, unaudited and unreviewed information on its financial performance for the year ended December 31, 2009. 2009 Financial Performance For the year ended December 31, 2009, Taro estimates net sales of $360.5 million, compared to estimated net sales of $336.7 million...
MINNEAPOLIS–NEWS–E. coli O145 outbreak at colleges in Michigan, Ohio and New York demonstrates need to regulate E. coli strains besides E. coli O157:H7. Non-O157 Shiga toxin-producing E. coli can cause HUS and TTP